Overall rank by patents
#2,391
Across all tracked assignees
USPTO PatentsView assignee record - 164 granted patents across 45 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H01L (SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10).
The verdict
X-celeprint holds 164 US patents across 45 technology areas, rank #2,391 of 50,000 tracked assignees.
X-celeprint Limited has been granted 164 US utility patents between 2016 and 2025, placing X-celeprint Limited at rank #2,391 across all assignees tracked by PlainPatent. This portfolio spans 45 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.2 claims per patent with primary concentration in H01L (SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10). As a Foreign Corporation, X-celeprint Limited is one of the more focused assignees in the PatentsView dataset. By volume, X-celeprint sits between Smiths Medical ASD, Inc. (164 patents, rank #2,387) and Ethertronics, Inc (163 patents, rank #2,395) - the closest US assignees by grant volume. The composite Innovation Score of 55.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 42 grants, compared with 122 in the 2015–2019 window, a -66% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. X-celeprint Limited's 19.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 45 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark X-celeprint Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Smiths Medical ASD, Inc.
164 patents
THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
164 patents
THE JAPAN STEEL WORKS, LTD.
164 patents
Univation Technologies, LLC
164 patents
X-Celeprint Limited
164 patents
ACACIA COMMUNICATIONS, INC.
163 patents
AMERICAN MEGATRENDS INTERNATIONAL, LLC
163 patents
Danziger “DAN” Flower Farm
163 patents
Ethertronics, Inc
163 patents
What this shows X-celeprint holds 164 patents at rank #2,391, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #2,391 in granted patent volume.
Other assignees with the most granted patents in X-celeprint's primary technology class.
X-celeprint's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
55 Top 7% higher than 93% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 7 | 4.3% |
| 2017 | 17 | 10.4% |
| 2018 | 41 | 25.0% |
| 2019 | 57 | 34.8% |
| 2020 | 3 | 1.8% |
| 2021 | 5 | 3.0% |
| 2022 | 7 | 4.3% |
| 2023 | 6 | 3.7% |
| 2024 | 11 | 6.7% |
| 2025 | 10 | 6.1% |
Top 15 of 45 technology areas
Overall rank by patents
#2,391
Across all tracked assignees
55.4 out of 100
How to use this portfolio
X-celeprint's 164 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.